Loading...
Danaher Corporation
DHR-PB•NYSE
Healthcare
Medical - Diagnostics & Research
$1261.26
$-9.94(-0.78%)
Danaher Corporation (DHR-PB) Financial Performance & Statements
Review Danaher Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.06%
↓ 0.06%
Operating Income Growth
-6.52%
↓ 6.52%
Net Income Growth
-18.16%
↓ 18.16%
Operating Cash Flow Growth
-6.64%
↓ 6.64%
Operating Margin
20.26%
↑ 20.26%
Gross Margin
59.74%
↑ 59.74%
Net Profit Margin
15.81%
↑ 15.81%
ROE
7.47%
↑ 7.47%
ROIC
6.66%
↑ 6.66%
Danaher Corporation (DHR-PB) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Danaher Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.54B | $5.80B | $5.74B | $5.80B |
| Cost of Revenue | $2.65B | $2.40B | $2.31B | $2.31B |
| Gross Profit | $3.89B | $3.40B | $3.43B | $3.49B |
| Gross Profit Ratio | $0.59 | $0.59 | $0.60 | $0.60 |
| R&D Expenses | $442.00M | $383.00M | $391.00M | $368.00M |
| SG&A Expenses | $2.02B | $2.06B | $1.87B | $1.81B |
| Operating Expenses | $2.46B | $2.44B | $2.26B | $2.17B |
| Total Costs & Expenses | $5.11B | $4.84B | $4.58B | $4.48B |
| Interest Income | $14.00M | $4.00M | $39.00M | $60.00M |
| Interest Expense | $61.00M | $87.00M | $65.00M | $65.00M |
| Depreciation & Amortization | $0.00 | $591.00M | $580.00M | $586.00M |
| EBITDA | $1.43B | $1.66B | $1.75B | $1.92B |
| EBITDA Ratio | $0.22 | $0.29 | $0.30 | $0.33 |
| Operating Income | $1.43B | $958.00M | $1.17B | $1.31B |
| Operating Income Ratio | $0.22 | $0.17 | $0.20 | $0.23 |
| Other Income/Expenses (Net) | -$110.00M | $19.00M | -$85.00M | -$41.00M |
| Income Before Tax | $1.31B | $977.00M | $1.08B | $1.27B |
| Income Before Tax Ratio | $0.20 | $0.17 | $0.19 | $0.22 |
| Income Tax Expense | $229.00M | $159.00M | $176.00M | $183.00M |
| Net Income | $1.09B | $818.00M | $907.00M | $1.09B |
| Net Income Ratio | $0.17 | $0.14 | $0.16 | $0.19 |
| EPS | $1.50 | $1.13 | $1.23 | $1.47 |
| Diluted EPS | $1.49 | $1.12 | $1.22 | $1.45 |
| Weighted Avg Shares Outstanding | $722.70M | $723.00M | $737.60M | $740.60M |
| Weighted Avg Shares Outstanding (Diluted) | $728.20M | $729.40M | $742.40M | $748.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan